Youth-Led Advocacy Takes Center Stage: The Fight for the Campus Lifeline Act on Capitol Hill on August 2, 2026 Posted by
Portable Shade: Why the Sun Umbrella Is an Essential Tool for Managing Dysautonomia on August 2, 2026 Posted by
Beyond Appetite: How New Oral GLP-1 Drugs Rewrite the Brain’s Reward Circuitry on August 2, 2026 Posted by
The Sleep-Stability Paradox: Navigating Bipolar Hypomania With Somatic Intervention on August 2, 2026 Posted by
The Culinary Paradox: Why Fried Ice Cream Remains an Iconic Dessert Staple on August 2, 2026 Posted by
The Trial of Lindsay Clancy: A Tragedy of Postpartum Care, Medication, and the Limits of Criminal Responsibility on August 2, 2026 Posted by
Youth-Led Advocacy Takes Center Stage: The Fight for the Campus Lifeline Act on Capitol Hill on August 2, 2026 Posted by
Portable Shade: Why the Sun Umbrella Is an Essential Tool for Managing Dysautonomia on August 2, 2026 Posted by
Beyond Appetite: How New Oral GLP-1 Drugs Rewrite the Brain’s Reward Circuitry on August 2, 2026 Posted by
Posted in Sleep Health The Equity Gap in Narcolepsy Care: New Data Reveals Disparities in Treatment Access on July 15, 2026
Posted in Sleep Health The Hidden Burden: Cognitive Impairment in Narcolepsy and Idiopathic Hypersomnia on July 14, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: Takeda’s Oveporexton Shows Promise in Phase 3 Clinical Trials on July 6, 2026
Posted in Sleep Health The Hidden Burden: New Study Reveals Cognitive Impairment as a Primary Driver of Disability in Narcolepsy and Idiopathic Hypersomnia on July 5, 2026
Posted in Sleep Health A New Dawn for Narcolepsy: Takeda’s Oveporexton Shows Transformative Potential in Phase 3 Trials on June 24, 2026
Posted in Sleep Health Beyond the Wakefulness Gap: How Cognitive Impairment Redefines Life with Narcolepsy and Idiopathic Hypersomnia on June 23, 2026
Posted in Sleep Health Decoding Narcolepsy: New Research Unlocks Potential for Simpler, More Accessible Diagnostic Testing on June 18, 2026
Posted in Sleep Health Advancing Sleep Medicine: Alkermes Secures Key Orphan Drug Designations for Alixorexton in Narcolepsy and Idiopathic Hypersomnia on June 17, 2026
Posted in Sleep Health Beyond Symptom Management: Takeda’s Oveporexton Shows Promise in Redefining Narcolepsy Type 1 Treatment on June 16, 2026
Posted in Sleep Health Unlocking the Orexin Mystery: A Breakthrough in Narcolepsy Diagnostics on June 6, 2026
